WASHINGTON — The Inter-American Development Bank (IDB) is lending $250 million to help Ecuador reduce morbidity and mortality from chronic, noncommunicable diseases by strengthening prevention, diagnosis, and access to comprehensive treatment.
The program, which has been approved by the IDB's Board of Executive Directors, will improve decision-making by creating clinical protocols and operational standards for health facilities, as well as by implementing information systems to monitor chronic diseases.
The operation will enable Ecuador to purchase equipment for primary care and specialized treatment of chronic diseases and cancer. It will also strengthen healthcare personnel and roll out an information system for better patient follow-up.
The program will benefit the estimated 10.2 million people of all ages served by Ecuador's Ministry of Public Health.
Chronic, noncommunicable diseases account for 53% of deaths in Ecuador. In 2023, cardiovascular diseases were the country’s leading cause of death.
The IDB loan has a 25-year repayment, a 5.5-year grace period, and an interest rate based on the Secured Overnight Financing Rate (SOFR).
About the IDB
The Inter-American Development Bank (IDB), a member of the IDB Group, is devoted to improving lives across Latin America and the Caribbean. Founded in 1959, the Bank works with the region’s public sector to design and enable impactful, innovative solutions for sustainable and inclusive development. Leveraging financing, technical expertise, and knowledge, it promotes growth and well-being in 26 countries. Visit our website: https://www.iadb.org/en.
Salgado Derqui,Javier Jose
